시장보고서

상품코드

1782024

세계의 갑상선암 진단 시장 : 제품별, 유형별, 기술별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Thyroid Cancer Diagnostics Market, By Product, By Type, By Technique, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 07월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 392 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계의 갑상선암 진단 시장 규모는 2024년 31억 6,724만 달러로, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 5.5%로 확대될 것으로 예상

갑상선암 진단 시장 - 시장 역학

갑상선암의 유병률 증가가 시장 성장을 가속할 것으로 예측됩니다.

갑상선암의 이환율이 계속 증가함에 따라 조기 및 정확한 진단 솔루션의 필요성이 현저하게 높아지고 있습니다. 이 개발의 결과, 고급 영상 진단법, 분자진단법, 저침습 생검법의 채용률이 높아지고 있으며, 모두 효과적인 질환의 식별, 분류, 치료 전략의 수립에 필수적입니다. 미국에서는 연간 약 53,000명이 갑상선암으로 진단되고 있습니다. 대부분의 갑상선암의 치료 성적은 매우 양호합니다. 그럼에도 불구하고 매년 약 2,000명이 이 질병으로 목숨을 잃고 있습니다. 또한, 건강 관리 지출 증가와 스크리닝 노력은 시장에 성장 기회를 제공합니다. 그러나 고급 진단 도구와 관련된 높은 비용은 시장 확대의 어려움이되었습니다.

갑상선암 진단 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2025-2032년)에 약 5.5%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측되고 있습니다.

제품 세분화별로는 계측이 2024년 최대 시장 점유율을 나타낼 것으로 예측됐습니다.

유형별로는 유두암이 2024년 주요 유형이었습니다.

기술 구분별로는 영상 기술이 2024년 주요 기술이었습니다.

최종 사용자별로는 병원이 2024년 주요 기술이었습니다.

지역별로는 북미가 2024년 매출을 이끌었습니다.

갑상선암 진단 시장 - 세분화 분석 :

세계의 갑상선암 진단 시장은 제품, 유형, 기술, 최종 사용자, 지역에 따라 세분화됩니다.

시장은 제품에 의해 장비, 장비, 소모품으로 분류됩니다. 장비는 시장 성장의 최전선에 있습니다. 갑상선 악성 종양의 정확하고 효율적인 검출을 촉진하는 데 필수적인 기능이기 때문에 갑상선암 진단 시장의 성장 촉진요인은 주로 장비입니다. 고급 영상 시스템, 분자진단 도구 및 생검 기기를 포함한 이러한 장비는 진단 정확도를 향상시키기 위해 임상 환경에서의 사용이 증가하고 있습니다. 조기 진단이나 병세 진행의 추적이 가능하기 때문에 갑상선암의 관리에는 빠뜨릴 수 없는 것이 되어 병원, 진단센터, 연구소에서 수요가 높아지고 있습니다.

시장은 유형에 따라 유두암, 여포암 등으로 구분됩니다. 유두암은 시장 성장을 이끌고 있습니다. 유두암은 갑상선암 진단 시장에서 큰 점유율을 차지하고 있으며, 갑상선암의 모든 유형 중에서 유병률이 높기 때문에 진단 증례의 대부분을 차지하고 있습니다. 특히 여성들 사이에서 그리고 건강 관리 시스템이 발달한 지역에서 이 하위유형의 발생률이 증가하고 있기 때문에 정확하고 조기 진단 솔루션에 대한 수요가 크게 증가하고 있습니다. 이 리더십은 갑상선 유두암 전용으로 설계된 진단 기술의 지속적인 개선의 필요성을 강조합니다.

시장은 진단 기술에 의해 혈액 검사, 영상 진단, 생검, 기타 부문으로 분류됩니다. 영상 기술은 시장 성장의 주요 촉진요인입니다. 영상 진단 기술은 갑상선 결절과 암의 조기 발견, 진단, 모니터링에 필수적인 기능으로 갑상선암 진단 시장의 확대에 크게 기여하고 있습니다. 초음파, 컴퓨터 단층촬영(CT), 자기공명영상법(MRI), 양전자방사단층촬영(PET) 등의 형태는 비침습적인 특성과 상세한 해부학적 및 기능적 정보를 제공하는 능력에 의해 널리 채택되고 있습니다. 이러한 양식 중에서 초음파 검사는 초기 평가에 가장 자주 사용되는 기술입니다.

시장은 최종 사용자에 의해 병원, 암 진단센터, 학술기관 및 연구기관, 기타 부문으로 분류됩니다. 병원은 광범위한 진단 인프라와 최첨단 의료 기술에 대한 액세스로 시장 성장의 최전선에 있습니다. 암 검진, 진단 및 치료의 주요 시설인 병원은 갑상선암을 정확하게 검출하는 데 필수적인 영상 진단 시스템, 분자진단 도구 및 생검 기기를 갖추고 있습니다. 환자의 유입 증가, 전문적인 건강 관리 전문가의 존재, 집학적 관리 접근법의 채용으로 병원 내 갑상선암 진단에 대한 수요가 더욱 높아지고 있습니다. 또한, 건강 관리 지출 증가와 병원 기반 진단 능력의 진보도 시장 확대에 기여하고 있습니다.

갑상선암 진단 시장 - 지리적 통찰

북미는 주로 암 진단 기술의 진보로 시장 성장을 이끌고 있습니다. 이 지역은 의료 인프라가 확립되어 있어 고급 화상 진단 시스템에 대한 액세스가 넓고 차세대 시퀀싱(NGS)이나 PCR 등의 분자진단 툴의 보급이 진행되고 있습니다. 미국만으로도 신규 진단자수는 190만명, 사망자수는 60만 9,360명으로 추정되고 있습니다. 양전자방사단층촬영법(PET), X선 컴퓨터 단층촬영법(CT), 자기공명분광법(MRS) 등 기존의 암진단법과 분자진단기술의 응용에 의해 조기 발견률이 향상되어 암 환자의 치료관리뿐만 아니라 암 자체의 조기 발견에도 중요한 역할을 하고 있습니다. 유럽은 높은 인지도, 강력한 헬스케어 시스템, 유리한 정책에 힘입어 시장 성장에 있어 2위를 차지하고 있습니다.

갑상선암 진단 시장 - 경쟁 구도 :

갑상선암 진단 시장은 전통적인 진단 약물 리더 기업, 전문성이 높은 생명 공학 기업, 신흥 기업에 의한 치열한 경쟁을 특징으로합니다. 각사는 진단 정밀도의 향상, 소요 시간의 단축, 지리적 범위의 확대를 목표로, 끊임없는 기술 혁신을 실시했습니다. 대기업은 경쟁 우위를 확보하기 위해 차세대 시퀀싱(NGS), AI를 활용한 영상 진단, 분자진단에 자원을 나누고 있습니다. 또한 갑상선암의 이환율 증가와 헬스케어 인프라 투자 증가를 이용하기 위해 유력 기업은 아시아태평양, 라틴아메리카, 중동 등 신흥 시장에 진출하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - 갑상선암 진단 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 프로파일
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd(Roche Diagnostics)
- Siemens Healthineers
- Thermo Fisher Scientific
- GE HealthCare
- Bio-Rad Laboratories
- Agilent Technologies
- Philips Healthcare
- Illumina, Inc.
- Daiichi Sankyo
- Hologic, Inc.
- Becton Dickinson
- PerkinElmer, Inc.
- Qiagen NV
- Veracyte, Inc.
- Exact Sciences
- NeoGenomics
- DiaSorin SpA
- Guardant Health
- Myriad Genetics
- 기타

제13장 애널리스트의 전방위적 전망

JHS

REPORT HIGHLIGHT

Thyroid Cancer Diagnostics Market size was valued at US$ 3,167.24 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.

The diagnosis of thyroid cancer encompasses a thorough array of tests aimed at identifying and verifying the existence of cancer in the thyroid gland. This process includes physical assessments, blood analyses, imaging methods, biopsy techniques, and molecular or genetic evaluations. Timely and precise diagnosis is crucial for formulating effective treatment strategies and management, greatly enhancing patient outcomes and long-term survival rates. Sophisticated diagnostic instruments are vital in facilitating the prompt detection and categorization of thyroid tumors, allowing for personalized and targeted treatment options.

Thyroid Cancer Diagnostics Market- Market Dynamics

The increasing prevalence of thyroid cancer is anticipated to drive the growth of the market.

As the incidence of thyroid cancers continues to increase, there is a significant rise in the need for early and precise diagnostic solutions. This development is resulting in higher adoption of sophisticated imaging methods, molecular diagnostics, and minimally invasive biopsy techniques, all of which are crucial for effective disease identification, categorization, and treatment strategy formulation. Approximately 53,000 individuals in the United States are diagnosed with thyroid cancer annually. The treatment outcomes for the majority of thyroid cancers are quite favorable. Nevertheless, around 2,000 individuals succumb to the disease each year. Additionally, the rise in healthcare expenditures and screening initiatives presents a growth opportunity for the market. However, the high costs associated with advanced diagnostic tools pose a challenge to market expansion.

Thyroid Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, Instruments was predicted to show maximum market share in the year 2024

Based on Type segmentation, Papillary carcinoma was the leading Type in 2024

Based on Technique segmentation, the Imaging Technique was the leading Technique in 2024

Based on End-User segmentation, Hospitals were the leading Technique in 2024

Based on region, North America was the leading revenue generator in 2024

Thyroid Cancer Diagnostics Market- Segmentation Analysis:

The Global Thyroid Cancer Diagnostics Market is segmented based on Product, Type, Technique, End-User, and Region.

The market is segmented into three categories according to Product: Instruments, Kits, and consumables. Instruments are at the forefront of market growth. Instruments are the primary drivers of growth in the Thyroid Cancer Diagnostics market due to their essential function in facilitating accurate and efficient detection of thyroid malignancies. These devices, which encompass advanced imaging systems, molecular diagnostic tools, and biopsy equipment, are being increasingly utilized in clinical environments to improve diagnostic accuracy. Their capability to aid in early diagnosis and track disease progression has rendered them crucial in the management of thyroid cancer, thus propelling their demand in hospitals, diagnostic centers, and research laboratories.

The market is segmented into two categories according to Type: Papillary carcinoma, Follicular carcinoma, and others. Papillary carcinoma leads the growth of the market. It holds a significant share in the Thyroid Cancer Diagnostics market, representing the majority of diagnosed cases due to its high prevalence among all types of thyroid cancer. The increasing incidence of this subtype, especially among women and in areas with developed healthcare systems, has greatly fueled the demand for precise and early diagnostic solutions. This leadership underscores the necessity for ongoing improvements in diagnostic technologies specifically designed for papillary thyroid carcinoma.

The market is categorized into three segments based on Technique: Blood test, Imaging, Biopsy, and Other. The Imaging Technique is the primary driver of market growth. Imaging techniques significantly contribute to the expansion of the Thyroid Cancer Diagnostics market, propelled by their essential function in the early detection, diagnosis, and monitoring of thyroid nodules and cancers. Modalities such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are extensively employed due to their non-invasive characteristics and their capacity to deliver detailed anatomical and functional information. Among these modalities, ultrasound is the most frequently utilized technique for initial assessment.

The market is categorized into three segments based on End-User: Hospitals, Cancer diagnostic centers, Academic and research institutes, and others. Hospitals are at the forefront of market growth due to their extensive diagnostic infrastructure and access to cutting-edge medical technologies. As the primary facilities for cancer screening, diagnosis, and treatment, hospitals are equipped with imaging systems, molecular diagnostic tools, and biopsy equipment that are crucial for the precise detection of thyroid cancer. The increasing influx of patients, the presence of specialized healthcare professionals, and the adoption of multidisciplinary care approaches further enhance the demand for thyroid cancer diagnostics within hospital environments. Moreover, the rise in healthcare spending and advancements in hospital-based diagnostic capabilities are also contributing to the expansion of the market.

Thyroid Cancer Diagnostics Market- Geographical Insights

North America leads in market growth, primarily due to advancements in cancer diagnostic technologies. The region has a well-established healthcare infrastructure, extensive access to advanced imaging systems, and a strong uptake of molecular diagnostic tools such as next-generation sequencing (NGS) and PCR. In the United States alone, the estimated figures for new diagnoses and deaths stand at 1.9 million and 609,360, respectively. The application of existing cancer diagnostic methods, including positron emission tomography (PET), X-ray computed tomography (CT), and magnetic resonance spectroscopy (MRS), along with molecular diagnostic techniques, has facilitated early detection rates and plays a crucial role not only in the therapeutic management of cancer patients but also in the early identification of cancer itself. Europe ranks as the second-largest region for market growth, supported by high awareness, strong healthcare systems, and favorable policies.

Thyroid Cancer Diagnostics Market- Competitive Landscape:

The market for thyroid cancer diagnostics is marked by fierce competition among well-established diagnostic leaders, specialized biotechnology companies, and new startups. Firms are persistently innovating to improve diagnostic precision, shorten turnaround times, and broaden their geographical reach. Major players are allocating resources toward next-generation sequencing (NGS), AI-enhanced imaging, and molecular diagnostics to secure a competitive advantage. Prominent companies are also venturing into emerging markets such as Asia-Pacific, Latin America, and the Middle East to take advantage of the growing incidence of thyroid cancer and the increased investment in healthcare infrastructure.

Recent Developments:

Thermo Fisher Scientific has announced that its in vitro diagnostic test, Oncomine, has been granted approval by the US Food and Drug Administration (FDA) for use as a companion diagnostic in grade 2 IDH-mutant glioma.

August 3, 2021 - NorthStar Medical Radioisotopes, LLC, a worldwide leader in the innovation, production, and commercialization of radiopharmaceuticals utilized for medical imaging and therapeutic purposes, along with GE Healthcare, has today declared the establishment of an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules within the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THYROID CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
F. Hoffmann-La Roche Ltd (Roche Diagnostics)
Siemens Healthineers
Thermo Fisher Scientific
GE HealthCare
Bio-Rad Laboratories
Agilent Technologies
Philips Healthcare
Illumina, Inc.
Daiichi Sankyo
Hologic, Inc.
Becton Dickinson
PerkinElmer, Inc.
Qiagen N.V.
Veracyte, Inc.
Exact Sciences
NeoGenomics
DiaSorin S.p.A.
Guardant Health
Myriad Genetics
Others

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Instruments
Kits & consumables

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Papillary carcinoma
Follicular carcinoma
Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

Blood test
Imaging
Biopsy
Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Cancer diagnostic centers
Academic and research institutes
Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Thyroid Cancer Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Thyroid Cancer Diagnostics Market Snippet by Product
- 2.1.2. Thyroid Cancer Diagnostics Market Snippet by Type
- 2.1.3. Thyroid Cancer Diagnostics Market Snippet by Technique
- 2.1.4. Thyroid Cancer Diagnostics Market Snippet by End-User
- 2.1.5. Thyroid Cancer Diagnostics Market Snippet by Country
- 2.1.6. Thyroid Cancer Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Thyroid Cancer Diagnostics Key Market Trends

3.1. Thyroid Cancer Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Thyroid Cancer Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Thyroid Cancer Diagnostics Market Opportunities
3.4. Thyroid Cancer Diagnostics Market Future Trends

4. Thyroid Cancer Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Thyroid Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Thyroid Cancer Diagnostics Market Landscape

6.1. Thyroid Cancer Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Thyroid Cancer Diagnostics Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Instruments
- 7.1.3. Kits & consumables

8. Thyroid Cancer Diagnostics Market - By Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 8.1.2. Papillary carcinoma
- 8.1.3. Follicular carcinoma
- 8.1.4. Other

9. Thyroid Cancer Diagnostics Market - By Technique

9.1. Overview
- 9.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
- 9.1.2. Blood test
- 9.1.3. Imaging
- 9.1.4. Biopsy
- 9.1.5. Other

10. Thyroid Cancer Diagnostics Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Cancer diagnostic centers
- 10.1.4. Academic and research institutes
- 10.1.5. Other

11. Thyroid Cancer Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Thyroid Cancer Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Thyroid Cancer Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Thyroid Cancer Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Thyroid Cancer Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Thyroid Cancer Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Thyroid Cancer Diagnostics Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. F. Hoffmann-La Roche Ltd (Roche Diagnostics)
- 12.2.3. Siemens Healthineers
- 12.2.4. Thermo Fisher Scientific
- 12.2.5. GE HealthCare
- 12.2.6. Bio-Rad Laboratories
- 12.2.7. Agilent Technologies
- 12.2.8. Philips Healthcare
- 12.2.9. Illumina, Inc.
- 12.2.10. Daiichi Sankyo
- 12.2.11. Hologic, Inc.
- 12.2.12. Becton Dickinson
- 12.2.13. PerkinElmer, Inc.
- 12.2.14. Qiagen N.V.
- 12.2.15. Veracyte, Inc.
- 12.2.16. Exact Sciences
- 12.2.17. NeoGenomics
- 12.2.18. DiaSorin S.p.A.
- 12.2.19. Guardant Health
- 12.2.20. Myriad Genetics
- 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us